KBRA Affirms All Ratings for MED 2024-MOB
7 May 2026 | New York
KBRA affirms its outstanding ratings for MED 2024-MOB, a CMBS single-borrower transaction. The affirmations follow a surveillance review of the transaction, which has exhibited stable collateral performance since securitization.
The transaction is secured by a $450.5 million non-recourse, first lien mortgage loan backed by a portfolio of 34 medical office buildings. The assets primarily have a concentration of tenants affiliated with a nearby hospital or large healthcare network (30 properties, 91.3% of loan balance) of which 22 (62.5%) are near a hospital campus. Four properties (8.7%) are both unaffiliated and off campus. The portfolio assets are located in 13 states, the three largest of which are New York (six, 29.4%), Texas (eight, 20.4%), and Indiana (six, 10.1%). The floating-rate loan has an initial two-year term with three one-year extension options and requires monthly interest-only payments based on one-month Term SOFR plus a spread of 2.40%. The initial maturity date is May 9, 2026, and according to the servicer, the first extension notice has been received and is under review. The sponsor of the borrowing entities is Starwood Property Trust, Inc. (NYSE: STWD), an affiliate of Starwood Capital Group (SCG).
KBRA analyzed the cash flow for the properties utilizing information from the trustee and servicer to determine KNCF. The analysis produced a KNCF of $42.9 million and a KBRA value of $481.8 million ($248 per sf). The resulting in-trust KLTV is 93.5%, compared to 95.2% at last review, and 95.0% at securitization. KBRA maintains a KPO of Perform on the loan.
To access ratings and relevant documents, click here.
Click here to view the report.